title: US Food and Drug Administration approval of drugs for the treatment of prostate cancer: a new era has begun.
authors.affiliation: Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA.
authors.forename: Anthony V
authors.initials: AV
authors.lastname: D'Amico
mesh_terms: D000736:Androstenes; D000737:Androstenols / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D000069448:Denosumab; D004164:Diphosphonates / Q000627:therapeutic use; D000077143:Docetaxel; D017277:Drug Approval; D015507:Drugs, Investigational; D004961:Estramustine / Q000627:therapeutic use; D017273:Goserelin / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D008297:Male; D008942:Mitoxantrone / Q000627:therapeutic use; D009570:Nitriles; D009842:Oligopeptides / Q000627:therapeutic use; D010669:Phenylthiohydantoin / Q000031:analogs & derivatives / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011868:Radioisotopes / Q000627:therapeutic use; D011883:Radium / Q000627:therapeutic use; D043823:Taxoids / Q000627:therapeutic use; D014020:Tissue Extracts / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration; D000077211:Zoledronic Acid
chemical_list: D000736:Androstenes; D000737:Androstenols; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D001549:Benzamides; D004164:Diphosphonates; D015507:Drugs, Investigational; D007093:Imidazoles; D009570:Nitriles; D009842:Oligopeptides; D011868:Radioisotopes; D043823:Taxoids; D014020:Tissue Extracts; C431566:acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide; D017273:Goserelin; D000077143:Docetaxel; D010669:Phenylthiohydantoin; D004961:Estramustine; D000069448:Denosumab; C552428:cabazitaxel; D000077211:Zoledronic Acid; C511774:sipuleucel-T; C540278:enzalutamide; D008942:Mitoxantrone; C089740:abiraterone; C581106:radium Ra 223 dichloride; D011883:Radium